SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 118 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,657,000 | +10.1% | 16,994 | +4.8% | 0.01% | +16.7% |
| Q4 2014 | $1,505,000 | +33.4% | 16,220 | -1.1% | 0.01% | +20.0% |
| Q3 2014 | $1,128,000 | -34.5% | 16,395 | -0.2% | 0.01% | -28.6% |
| Q2 2014 | $1,722,000 | +35.9% | 16,434 | +7.6% | 0.01% | +16.7% |
| Q1 2014 | $1,267,000 | +31.7% | 15,269 | +2.7% | 0.01% | +50.0% |
| Q4 2013 | $962,000 | +12.1% | 14,865 | +9.6% | 0.00% | 0.0% |
| Q3 2013 | $858,000 | -35.4% | 13,557 | -57.1% | 0.00% | -42.9% |
| Q2 2013 | $1,328,000 | – | 31,609 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|